Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L O Almér

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Acta Endocrinologica. Supplementum|January 1, 1980
Vascular fibrinolytic activity in long term treatment with second generation sulfonylurea compoundsL O Almér
Thrombosis Research|July 1, 1984
Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetesL O Almér
Acta Medica Scandinavica|January 1, 1985
A case of brucellosis complicated by endocarditis and disseminated intravascular coagulationL O Almér
Acta Medica Scandinavica. Supplementum|January 1, 1981
On some factors related to the pathogenesis of diabetic angiopathyL O Almér
Acta Medica Scandinavica. Supplementum|January 1, 1983
Evaluation of a new semiquantitative test strip for urine glucose determinationL O Almér
Journal of Medicine|January 1, 1975
Effect of obesity on endogenous fibrinolytic activity in diabetes mellitusL O Almér
Thrombosis Research|July 1, 1975
Fibrinolysis in relation to circulation through the legs in diabeticsL O Almér, B Lilja
Thrombosis Research|August 1, 1987
Elevated levels of the rapid inhibitor of plasminogen activator (t-PAI) in acute myocardial infarctionL O Almér, H Ohlin
Thrombosis Research|February 1, 1975
Low vascular fibrinolytic activity in obesityL O Almér, L Janzon
Diabetes Research (Edinburgh, Scotland)|November 1, 1984
On plasma chlorpropamide, body weight and sex difference in chlorpropamide alcohol flush (CPAF)P Jerntorp, L O Almér
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Acta Endocrinologica. Supplementum|January 1, 1980
Vascular fibrinolytic activity in long term treatment with second generation sulfonylurea compoundsL O Almér
Thrombosis Research|July 1, 1984
Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetesL O Almér
Acta Medica Scandinavica|January 1, 1985
A case of brucellosis complicated by endocarditis and disseminated intravascular coagulationL O Almér
Acta Medica Scandinavica. Supplementum|January 1, 1981
On some factors related to the pathogenesis of diabetic angiopathyL O Almér
Acta Medica Scandinavica. Supplementum|January 1, 1983
Evaluation of a new semiquantitative test strip for urine glucose determinationL O Almér
Journal of Medicine|January 1, 1975
Effect of obesity on endogenous fibrinolytic activity in diabetes mellitusL O Almér
Thrombosis Research|July 1, 1975
Fibrinolysis in relation to circulation through the legs in diabeticsL O Almér, B Lilja
Thrombosis Research|August 1, 1987
Elevated levels of the rapid inhibitor of plasminogen activator (t-PAI) in acute myocardial infarctionL O Almér, H Ohlin
Thrombosis Research|February 1, 1975
Low vascular fibrinolytic activity in obesityL O Almér, L Janzon
Diabetes Research (Edinburgh, Scotland)|November 1, 1984
On plasma chlorpropamide, body weight and sex difference in chlorpropamide alcohol flush (CPAF)P Jerntorp, L O Almér
Pageof 6